Drug Patent List
Oppositions
Newsletter
Weekly Digest

Pharsight

Chloroprocaine Hydrochloride Patent Expiration

Chloroprocaine Hydrochloride is Used for regional anesthesia through intrathecal administration. It was first introduced by Fresenius Kabi Usa Llc in its drug Nesacaine on Approved Prior to Jan 1, 1982. Other drugs containing Chloroprocaine Hydrochloride are Iheezo, Nesacaine-Mpf, Clorotekal. 5 different companies have introduced drugs containing Chloroprocaine Hydrochloride.


Chloroprocaine Hydrochloride Patents

Given below is the list of patents protecting Chloroprocaine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Clorotekal US8969412 Use for a composition comprising chloroprocaine HCL, a new composition comprising chloroprocaine HCL and a method for its manufacture Sep 05, 2026 B Braun Medical Inc
Clorotekal US9504666 Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration Dec 11, 2033 B Braun Medical Inc
Iheezo US10792271 Topical formulations of chloroprocaine and methods of using same Sep 15, 2038 Harrow Eye


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Chloroprocaine Hydrochloride Generics

Several generic applications have been filed for Chloroprocaine Hydrochloride. The first generic version for Chloroprocaine Hydrochloride was by Hospira Inc and was approved on Apr 16, 1982. And the latest generic version is by Hikma Pharmaceuticals Usa Inc and was approved on Sep 9, 1998.

Given below is the list of companies who have filed for Chloroprocaine Hydrochloride generic.


1. HOSPIRA

Hospira Inc has filed for 2 different strengths of generic version for Chloroprocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Hospira.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3% injectable Discontinued INJECTION N/A Apr 16, 1982
2% injectable Discontinued INJECTION N/A Apr 16, 1982


2. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Chloroprocaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2% injectable Prescription INJECTION AP Sep 9, 1998
3% injectable Prescription INJECTION AP Sep 9, 1998